Here is a detailed overview of oral contraceptive (OC) pills based on authoritative medical textbooks:
Oral Contraceptive (OC) Pills
Types
1. Combined Oral Contraceptive Pills (COCPs)
- Contain ethinyl estradiol (estrogen component) + a progestin
- Progestins come in 4 generations, each with different androgenic profiles and side effects
- Lower-dose modern pills have fewer metabolic side effects than older high-dose formulations
2. Progestin-Only Pills (Mini-Pills)
- Contain only a progestin (e.g., norethindrone)
- Used when estrogen is contraindicated (e.g., breastfeeding, smoking over 35)
Mechanism of Action
COCPs work through three main mechanisms:
| Mechanism | Details |
|---|
| Ovulation suppression | Exogenous hormones suppress the hypothalamic-pituitary-ovarian (HPO) axis, inhibiting LH/FSH surges and preventing follicular maturation |
| Cervical mucus thickening | Progestin cross-links cervical mucus, making it impenetrable to sperm - especially important in low-dose pills |
| Endometrial alteration | Alters endometrial receptivity to the fertilized ovum, making implantation unlikely |
Progestin-only pills rely more on thickening cervical mucus and have weaker ovulation suppression.
Non-Contraceptive Benefits
- Reduced dysmenorrhea and ovulatory pain (mittelschmerz)
- Improvement of acne vulgaris and hirsutism (especially with anti-androgenic progestins)
- Regulation of menstrual cycles
- Reduced iron-deficiency anemia (lighter periods)
- Decreased risk of ovarian and endometrial cancers (50% reduction in endometrial cancer; effect persists 15 years after stopping)
- Decreased risk of colorectal cancer
- Reduced incidence of pelvic inflammatory disease (PID)
Adverse Effects
Estrogen excess:
- Nausea, breast tenderness
- Edema, headache
- Increased clotting factors (thromboembolic risk)
- Hypertension
Progestin excess:
- Depression, decreased libido, fatigue
- Weight gain
- Decreased HDL, increased LDL
- Decreased glucose tolerance (diabetogenic)
Androgenic effects (19-norprogestins):
- Acne, hirsutism, oily skin
- Cholestatic jaundice (rare)
Breakthrough bleeding (BTB):
- Most commonly due to non-compliance
- Usually resolves within the first 3 cycles
Serious Complications
- Thromboembolic events (DVT, PE) - related to estrogen component
- Arterial thrombosis - stroke, myocardial infarction (especially in smokers and migraineurs with aura)
- Hypertension
- Hepatic adenoma (rare)
The ethinyl estradiol causes dose-dependent increases in pro-coagulant serum factors. In healthy non-smokers, compensatory fibrinolytic activity offsets this, but smokers lose this protective effect.
Contraindications
Absolute Contraindications
| Condition |
|---|
| Acute mononucleosis |
| History of cerebrovascular accident (stroke) |
| Coronary artery disease |
| Known/suspected breast carcinoma |
| Estrogen-dependent neoplasia |
| Malignant or benign liver neoplasm |
| Thrombophlebitis or thromboembolic disorder (including Factor V Leiden carriers) |
| Known or suspected pregnancy |
| Classic migraines (with aura) |
| Women age ≥35 who smoke |
Relative Contraindications
| Condition |
|---|
| Term pregnancy within the previous 3 weeks |
| Hypertension ≥140/90 mmHg on three visits |
| Diastolic BP >110 mmHg on one visit |
| Impaired liver function |
| Breastfeeding (lactation) |
| Major surgery or lower limb immobilization planned within 4 weeks |
| Previous cholestasis of pregnancy |
| Undiagnosed abnormal vaginal bleeding |
Note: Common migraines without aura and obesity are not absolute contraindications to COC use.
Initiating OC Pills
- Quick-start method: Begin on the day of the office visit - associated with higher adherence at 3 months and no higher risk of irregular bleeding
- Traditional Sunday start or first-day-of-period start: Still widely used
- If adverse effects persist beyond 3 months, they are considered valid and a pill switch is warranted
Progestin-Only Pill Specifics
- Preferred for breastfeeding mothers (does not reduce lactation unlike estrogen-containing pills)
- No increased risk of thromboembolic events
- Main side effect: irregular, unpredictable spotting/breakthrough bleeding - the primary reason for discontinuation
Sources: Swanson's Family Medicine Review, 8th ed. | Textbook of Family Medicine, 9th ed. | Goodman & Gilman's Pharmacological Basis of Therapeutics